(3S)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid - 2-hydroxypropanoic acid (1:1)(CAS: 294662-18-3)

This compound is a pharmaceutical intermediate with a complex structure. It contains a quinoline ring, a piperazine group, and a 1,4-oxazino[2,3,4-ij]quinoline core, along with a hydroxycarboxylic acid moiety. It is used in the synthesis of drugs targeting neurological and psychiatric conditions.

This compound is primarily used as an intermediate for the synthesis of pharmaceuticals, specifically in developing new drugs for treating neurological and psychiatric disorders. It plays a crucial role in the customization of active drug ingredients.

The compound is safe when handled according to standard safety practices. It should be stored away from direct sunlight, kept in a cool, dry place, and used in a well-ventilated area. Protective gloves and goggles should be worn during handling to prevent skin and eye contact.

This compound should be stored at temperatures between 15-25°C, away from direct sunlight and moisture. It should be kept in a tightly sealed container to prevent degradation. Any unused portions should be disposed of according to local regulations for hazardous chemicals.